Travoprost ophthalmic (Ocular Therapeutix)

N/A

Report date: 2023/08/22 17:03:41

Base Information

Drug NameTravoprost ophthalmic (Ocular Therapeutix)
Drug Alias NameTravoprost intracameral implantTravoprost ophthalmic insertSustained release travoprostTravoprost implantIntracanalicular travoprost insert +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin F2 alpha agonists
TargetsProstaglandin F2 alpha
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaSouth Korea +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesOcular Therapeutix Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaukos CorpOcular Therapeutix IncAffamed Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A